Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Chemical profiling of Jianwei Xiaoshi oral liquid and its potential mechanism of effect on high-calorie diet-induced dyspepsia in immature rats: gut flora, transcriptomics and network pharmacology

ABSTRACT: Chemical profiling of Jianwei Xiaoshi oral liquid and its potential mechanism of effect on high-calorie diet-induced dyspepsia in immature rats: gut flora, transcriptomics and network pharmacology

PROVIDER: PRJNA1030034 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Chemical profiling of Jianwei Xiaoshi oral liquid and its potential mechanism of effect on high-calorie diet-induced dyspepsia in immature rats: gut flora, transcriptomics and network pharmacology

Project description:Gene expression was detected using duodenal samples to identify the key regulatory genes for the treatment of dyspepsia with Jianwei Xiaoshi oral liquid

2023-12-31 | GSE245835 | GEO

Duodenal Mucosal Barrier in Functional Dyspepsia [miRNA]

Project description:Epithelial Barrier and Leaky Gut in Dyspepsia Running title: Epithelial Barrier and Leaky Gut in Dyspepsia Context: Some studies suggest that FD is associated with ex vivo duodenal epithelial micro-inflammation and barrier impairment; the pathogenesis of these findings is unclear. miRNAs reduce expression of epithelial barrier genes and have been postulated to increase epithelial permeability in irritable bowel syndrome. New findings: Compared to controls, there is reduced mRNA expression of several barrier proteins (zona occludin-1), increased expression of several miRNAs (eg, miR-142-3p) that suppress the genes for barrier proteins in FD. However, mucosal eosinophils, intraepithelial lymphocytes, and mast cells, ex- and in vivo permeability (urinary lactulose and mannitol excretion) were not significantly different in FD. Impact: Patients with FD do not have a leaky gut syndrome.

2023-03-01 | GSE169307 | GEO

Duodenal Mucosal Barrier in Functional Dyspepsia [mRNA]

2023-03-01 | GSE169304 | GEO

Duodenal Mucosal Barrier in Functional Dyspepsia

Project description:Duodenal Mucosal Barrier in Functional Dyspepsia

| PRJNA716241 | ENA

Comparison between calorie-restricted and time-restricted without calorie restriction

Project description:Comparison between calorie-restricted and time-restricted without calorie restriction

| PRJNA706697 | ENA

Calorie restriction and aging

Project description:Gene expression profiles of kidney tissue from control-fed 5-month-old, control-fed 30-month-old and calorie restricted 30 month-old C57BL/6 mice. Keywords = kidney, aging, calorie restriction Keywords: other

2003-06-23 | GSE459 | GEO

Duodenal Mucosal Barrier in Functional Dyspepsia [mRNA]

Project description:Duodenal Mucosal Barrier in Functional Dyspepsia [mRNA]

| PRJNA716245 | ENA

Duodenal Mucosal Barrier in Functional Dyspepsia [miRNA]

Project description:Duodenal Mucosal Barrier in Functional Dyspepsia [miRNA]

| PRJNA716246 | ENA

Mechanisms of Action of Fu Fang Gang Liu Liquid in Treating Condyloma Acuminatum by Network Pharmacology and Experimental Validation

Project description:Condyloma acuminatum is a sexually transmitted disease characterized by the anomalous proliferation of keratinocytes caused by human papillomavirus (HPV) infection. Fu Fang Gang Liu liquid (FFGL) is an effective external prescription to treat condyloma acuminatum, but its potential molecular mechanism is still unclear. This study aimed to identify the major active ingredients and prospective targets of FFGL by using network pharmacology, molecular docking, and transcriptomics, and validating it experimentally. Network pharmacology analysis found that FFGL contains a total of 78 active compounds, from which 610 compound-related targets were screened. Among them, 59 compound-related targets overlapped with CA targets and were considered as targets with potential therapeutic effects. Protein-protein network analysis showed that AKT serine/threonine kinase 1 was the potential therapeutic target. To further confirm this result we performed RNA-seq assays on HPV18+ cells after FFGL intervention, and conducted enrichment analyses on the screened differentially expressed genes. Enrichment analyses results indicated that the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) pathway may be a key pathway for FFGL to function. Further in vitro experiments revealed that FFGL significantly inhibited the activity of HPV18+ cells and reduced PI3K and Akt protein levels. Rescue experiment indicated that the reduction in cell viability caused by FFGL was partially restored after the use of activators of the PI3K/Akt pathway. We further explored the active components of FFCL for the treatment of condyloma acuminatum and screened two active compounds, periplogenin and periplocymarin. Molecular docking showed that these two compounds have good binding activity to AKT1.

2023-04-26 | GSE223380 | GEO

Transcriptomics profiling of ccc_R08 for mechanism-of-action investigation with forward pharmacology

Project description:To investigate the mode of action of ccc_R08, a first-in-class orally available HBV cccDNA inhibitor, we designed and implemented two orthogonal and complementary approaches: a forward pharmacology approach and a reverse pharmacology approach. Bioinformatics analysis integrating biological knowledge with the observations from both approaches offered us preliminary insights into the mode of action of ccc_R08.

2022-12-30 | GSE214515 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data